A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis

Donald E. Goodkin, M. Shulman, J. Winkelhake, E. Waubant, P. B. Andersson, T. Stewart, S. Nelson, N. Fischbein, P. K. Coyle, Elliot Frohman, L. Jacobs, J. Holcenberg, M. Lee, S. Mocci

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences